๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Population Pharmacokinetics of Belimumab Following Intravenous Administration in Patients With Systemic Lupus Erythematosus

โœ Scribed by Struemper, Herbert; Chen, Cecil; Cai, Wendy

Book ID
120473222
Publisher
Sage Publications
Year
2013
Tongue
English
Weight
518 KB
Volume
53
Category
Article
ISSN
0091-2700

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics and immunoglobulin resp
Pharmacokinetics and immunoglobulin response of subcutaneous and intravenous atacicept in patients with systemic lupus erythematosus
โœ I. Nestorov; O. Papasouliotis; C. Pena Rossi; A. Munafo ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 386 KB

Atacicept, a recombinant fusion protein of the TACI receptor and human IgG, is an inhibitor of B-Lymphocyte Stimulator (BLyS) and APRIL, potent stimulators of B cell maturation, proliferation, and survival. Pharmacokinetics (PKs) and biological activity of intravenous (iv) and subcutaneous (sc) atac